Triumvira Immunologics Revenue

Biotechnology Research • 4 Embarcadero Ctr, San Francisco, United States • 21-50 Employees

Triumvira Immunologics revenue & valuation

Annual revenue	$8,400,000
Revenue per employee	$336,000
Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues	$26,900,000
Total funding	$45,000,000

Key Contacts at Triumvira Immunologics

Jolyn Johnson

Director Of Manufacturing

Kara Moss

Senior Director Clinical Operations

Leslie Gorospe

Senior Director, Controller

Chris Ayers

Scientific Director, Msat

Nader Ghazanfari

Director, Quality Control

Company overview

Headquarters	4 Embarcadero Ctr, San Francisco, California 94111, US
Phone number	+12018824550
Website	triumvira.com
NAICS	541714
SIC	283
Keywords	Partnerships, Oncology, Immunology, Cell And Gene Therapy, Clinical Developement, T Cell Antigen Coupler
Founded	2015
Employees	21-50
Socials

Triumvira Immunologics Email Formats

Triumvira Immunologics uses 3 email formats. The most common is {first initial}{last name} (e.g., jdoe@triumvira.com), used 66.7% of the time.

Format	Example	Percentage
{first initial}{last name}	jdoe@triumvira.com	66.7%
{first name}{last name}	johndoe@triumvira.com	26.7%
{last name}{last name}	doedoe@triumvira.com	6.7%

About Triumvira Immunologics

At Triumvira Immunologics, Inc., our team is dedicated to a vision of finding a cure and providing new hope for patients with life-threatening disease. Co-founded in 2015 by licensing technology out of McMaster University and Bloom Burton & Co., Triumvira is working to achieve this vision by developing a proprietary T cell Antigen Coupler (TAC) technology, thought to be safer and more efficacious than current cancer treatments including chimeric antigen receptor (CAR) and engineered T cell receptor (TCR) therapies. We are an emergent US company headquartered in San Francisco. We bring together talent from a wide range of disciplines including immunobiology, drug development, fundraising, commercialization and finance, with decades of experience across big pharma and small biotech, multiple industries and academia. We are passionate about science that pushes the limits, the patients that drive the heart of our work, and the wellness of our employees. We embrace flexibility. If you are looking for a career where you are encouraged to be innovative, challenge the status quo, and have some fun while doing it, Triumvira is the place for you. For more information about Triumvira career opportunities, please see our Careers web page at: https://triumvira.com/contact-us/careers/

Employees by Management Level

Total employees: 21-50

Seniority

Employees

Director

Entry

Manager

Employees by Department

Triumvira Immunologics has 7 employees across 3 departments.

Departments

Number of employees

Funding Data

Explore Triumvira Immunologics's funding history, including investment rounds, total capital raised, and key backers.

Funding Date	Round	Amount	Link to Article
2022-04-17	4	$45,000,000

Funding Insights

$45,000,000

Total funding amount

$45,000,000

Most recent funding amount

Number of funding rounds

Triumvira Immunologics Tech Stack

Discover the technologies and tools that power Triumvira Immunologics's digital infrastructure, from frameworks to analytics platforms.

GoDaddy

Hosting

Nginx

Reverse proxies

Microsoft 365

Frequently asked questions

Triumvira Immunologics is located in 4 Embarcadero Ctr, San Francisco, US.

You can reach Triumvira Immunologics at +12018824550.

Triumvira Immunologics generates an estimated annual revenue of $8,400,000. This revenue figure reflects the company's market position and business performance in its industry.

Triumvira Immunologics has an estimated valuation of $26,900,000. This valuation is calculated based on industry-standard revenue multiples and reflects the company's growth potential and market positioning.

Triumvira Immunologics was founded in 2015, making it 11 years old. The company has established itself as a significant player in its industry over this time.

Triumvira Immunologics has approximately 21-50 employees. The company continues to grow its workforce to support its business operations and expansion.

Triumvira Immunologics has raised a total of $45,000,000 across 1 funding rounds. This investment has helped the company grow and expand its operations.